The association of PD-L1 expression status and the PD-1/PD-L1 inhibitor-related toxicity profile in non-small cell lung cancer

Abstract Objective While PD-L1 expression serves as a predictive biomarker for programmed cell death 1 and its ligand (PD-1/PD-L1) inhibitor efficacy in patients with non-small cell lung cancer (NSCLC), its association with treatment-related adverse events (TRAEs) has yet to be fully elucidated. Thi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Qian Zhu, Hao Hu, Li-Ying OuYang, Rong Yang, Wen-Xiao Wei, Pin Huang, Xin-Rong He
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-04-01
Edice:	BMC Cancer
Témata:	PD-L1 expression PD-1/PD-L1 inhibitor Toxicity profile Non-small cell lung cancer
On-line přístup:	https://doi.org/10.1186/s12885-025-14218-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!